Sridharan Gururangan

Hematology | Oncology

1600 SW Archer Rd # 100371
Gainesville, FL 32610

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908.

Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908.

Journal: Neuro-oncology

Published: February 22, 2023

Upfront Adjuvant Immunotherapy of Replication Repair-Deficient Pediatric Glioblastoma With Chemoradiation-Sparing Approach.

Upfront Adjuvant Immunotherapy of Replication Repair-Deficient Pediatric Glioblastoma With Chemoradiation-Sparing Approach.

Journal: JCO precision oncology

Published: January 07, 2022

Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry.

Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry.

Journal: Neuro-oncology

Published: October 20, 2021

Correction to: Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.

Correction to: Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.

Journal: Journal of neuro-oncology

Published: July 01, 2021

Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry.

Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry.

Journal: Neuro-oncology

Published: June 11, 2021

Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.

Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.

Journal: Journal of neuro-oncology

Published: May 06, 2021

A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.

A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.

Journal: Neuro-oncology

Published: February 25, 2021

Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.

Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.

Journal: Cancer cell

Published: February 08, 2021

Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.

Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 27, 2021

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 06, 2021

Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials.

Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 05, 2020

A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042).

A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042).

Journal: Pediatric blood & cancer

Published: October 06, 2020

Showing 1-12 of 45

Last Updated: 09/26/2026